The Goldman Sachs-owned broker has landed its second deal of the week

Aston Lark has sealed its second deal of the week, this time buying Incepta Risk Management, a Lloyd’s broker.

Incepta offers both direct and wholesale solutions. The wholesale unit focuses on property, casualty, and professional indemnity business in the London Market to brokers, Aston Lark said.

Incepta’s nine staff are based in Fenchurch Street, London.

Commenting on the acquisition, Aston Lark chief executive Peter Blanc said: ”Aston Lark is well known for our regional presence, but we see the London Market becoming increasingly important to the group and a key element of our future growth strategy.

 “We’ve been keen to expand our London Market offering since our acquisition of Lloyd’s broker Protean Risk in October 2019.

Our Irish colleagues in Robertson Low, which we acquired in January 2019, also trade significantly with the London Market and our acquisition of Incepta therefore joins the dots in making the London Market an important pillar of Aston Lark’s offering, alongside our UK retail and Irish businesses.

”We continue to explore other acquisition opportunities in the London Market space and are interested in speaking to any individuals or teams who may be considering a move.”

On 3 August the Goldman Sachs-backed firm bought specialist intermediary Private Healthcare Managers (PHM Ltd).

Incepta director Paul Smith the company “has grown into a successful service-driven business”.

”Through teamwork with our staff of talented individuals we have consistently punched above our weight in a competitive marketplace.

”Joining the Aston Lark group was a logical step for us as they conduct their business in the same way we do. It’s an extremely good fit for both Aston Lark and ourselves and the future is very bright for our team and our customers.”